Fangda represented HLC on the deal. Viva Biotech Holdings Group completed the equity financing at both Viva Holdings and its subsidiary Viva Biotech (Shanghai) Ltd., bringing in...
Viva Biotech Holdings Group’s Investment Round
Huaxin Cement Co., Ltd.’s Hong Kong Listing By Way of Introduction
Clifford Chance advised Huaxin Cement Co., Ltd., Fangda and Grandall advised Shenwan Hongyuan Capital (H.K.) Limited. Huaxin Cement Co., Ltd. announced its B to H Share listing...
Jinmao Services’ Initial Public Offering
Fangda advised a syndicate of underwriters on the deal. Latham & Watkins advised Jinmao Property Services Co. Limited (Jinmao Services). Jinmao Services executed its initial public...